Statement Of Financial Position [Abstract]

Ascelia Pharma - Filing #701899

Concept As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2020-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
As at
2019-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
238,000 SEK
301,000 SEK
Right-of-use assets
1 581 SEK
1 688 SEK
Intangible assets other than goodwill
57 063 SEK
57 061 SEK
Non-current assets
58 882 SEK
59 050 SEK
Current assets [abstract]
Current tax assets, current
4 395 SEK
1 748 SEK
Cash and cash equivalents
261 599 SEK
184 686 SEK
108 516 SEK
Current assets
274 611 SEK
196 324 SEK
Assets
333 493 SEK
255 374 SEK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
34 576 SEK
28 697 SEK
Retained earnings
405 827 SEK
286 491 SEK
Equity attributable to owners of parent
307 834 SEK
236 056 SEK
Equity
405 827 SEK
678 831 SEK
307 834 SEK
307 834 SEK
SEK
254,000 SEK
34 576 SEK
286 491 SEK
SEK
493 731 SEK
236 056 SEK
28 697 SEK
119,000 SEK
236 056 SEK
237 062 SEK
SEK
124,000 SEK
405 061 SEK
237 062 SEK
191 612 SEK
23 489 SEK
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities
553,000 SEK
956,000 SEK
Current liabilities [abstract]
Current tax liabilities, current
5,000 SEK
- SEK
Current liabilities
25 106 SEK
18 362 SEK
Liabilities
25 659 SEK
19 318 SEK
Equity and liabilities
333 493 SEK
255 374 SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.